发明名称 |
HMG CoA REDUCTASE MEDIATED MODULATION OF NEUROGENESIS |
摘要 |
The instant disclosure describes methods of treating diseases and conditions of the central and peripheral nervous system including by stimulating or increasing neurogenesis, neuroproliferation, and/or neurodifferentiation. The disclosure includes compositions and methods based on use of an HMGCR modulating agent, optionally in combination with one or more other neurogenic agents, to stimulate or increase a neurogenic response and/or to treat disease.
|
申请公布号 |
US2008103105(A1) |
申请公布日期 |
2008.05.01 |
申请号 |
US20070858790 |
申请日期 |
2007.09.20 |
申请人 |
BRAINCELLS, INC. |
发明人 |
BARLOW CARROLEE;CARTER TODD A.;MORSE ANDREW;TREUNER KAI;LORRAIN KYM I.;REDWINE JEFF;HOFFMASTER CHRISTINE |
分类号 |
A61K31/7056;A61K31/222;A61K31/351;A61K31/40;A61K31/404;A61K31/44;A61K31/443;A61K31/4525;A61K31/473;A61K31/497;A61K31/4985;A61K31/505;A61P25/00;C12N5/08 |
主分类号 |
A61K31/7056 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|